These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Experience with ciclesonide in patients with mild persistent bronchial asthma]. Bartosíková L; Necas J; Frána L; Bartosík T Ceska Slov Farm; 2007 Dec; 56(6):276-9. PubMed ID: 18257418 [TBL] [Abstract][Full Text] [Related]
24. The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide. Meltzer EO; Derendorf H Ann Allergy Asthma Immunol; 2006 Aug; 97(2):149-57. PubMed ID: 16937743 [TBL] [Abstract][Full Text] [Related]
25. Intermittent or daily montelukast versus placebo for episodic asthma in children. Valovirta E; Boza ML; Robertson CF; Verbruggen N; Smugar SS; Nelsen LM; Knorr BA; Reiss TF; Philip G; Gurner DM Ann Allergy Asthma Immunol; 2011 Jun; 106(6):518-26. PubMed ID: 21624752 [TBL] [Abstract][Full Text] [Related]
26. The ethics of placebo-controlled trials: the case of asthma. Onder RF J Allergy Clin Immunol; 2005 Jun; 115(6):1228-34. PubMed ID: 15940139 [TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270 [TBL] [Abstract][Full Text] [Related]
29. [Ciclesonide in the treatment of patients with bronchial asthma]. Targowski T; Płusa T; Grabowska P Pol Merkur Lekarski; 2005 Dec; 19(114):735-8. PubMed ID: 16521412 [TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266 [TBL] [Abstract][Full Text] [Related]
31. Budesonide/formoterol (Symbicort) for asthma. Med Lett Drugs Ther; 2008 Feb; 50(1279):9-11. PubMed ID: 18264031 [No Abstract] [Full Text] [Related]
32. Comparative study of cloprednol versus placebo in asthma. Goodman DH Ann Allergy; 1978 Jun; 40(6):376-80. PubMed ID: 352197 [TBL] [Abstract][Full Text] [Related]
33. Comparison of inhaled corticosteroids: an update. Kelly HW Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959 [TBL] [Abstract][Full Text] [Related]
34. Drugs for asthma. Treat Guidel Med Lett; 2002 Oct; 1(2):7-12. PubMed ID: 15529100 [No Abstract] [Full Text] [Related]
35. The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide? van der Molen T; Kocks JW NPJ Prim Care Respir Med; 2014 May; 24():14013. PubMed ID: 24841448 [No Abstract] [Full Text] [Related]
36. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma]. Michils A; Sternon J J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881 [TBL] [Abstract][Full Text] [Related]
37. The protective effect of inhaled terbutaline, sodium cromoglycate and budesonide on exercise-induced asthma in children. Pichaipat V; Tongpenyai Y; Nerntong T; Sriprapachiranont C J Med Assoc Thai; 1995 Oct; 78(10):505-8. PubMed ID: 8576655 [TBL] [Abstract][Full Text] [Related]
39. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. Virchow JC; Mehta A; Ljungblad L; Mitfessel H J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152 [TBL] [Abstract][Full Text] [Related]